Septy Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-11-2024
- Paid Up Capital ₹ 1.00 M
as on 02-11-2024
- Company Age 2 Year, 5 Months
About Septy Biosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Anju Kumari and Suresh Saini serve as directors at the Company.
- CIN/LLPIN
U24230HP2022PTC009448
- Company No.
009448
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2022
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Septy Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Saini  | Managing Director | 18-Jul-2022 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anju Kumari | Director | 18-Jul-2022 | Current |
Financial Performance of Septy Biosciences.
Enhance accessibility to Septy Biosciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Septy Biosciences?
Unlock access to Septy Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Septy Pharmaceuticals Private LimitedActive 18 years 7 monthsAnju Kumari and Suresh Saini are mutual person
Innocosmetica Wellness LimitedActive 9 months 12 daysAnju Kumari and Suresh Saini are mutual person
- Anjushree Lifescience Private LimitedActive 4 years 4 months
Anju Kumari and Suresh Saini are mutual person
- Alkon Formulation Private LimitedActive 7 years 11 months
Anju Kumari and Suresh Saini are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Septy Biosciences?
Septy Biosciences has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Septy Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Septy Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
